Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania. The company went IPO on 2019-05-30. The company provides laboratory and related services to pharmaceutical and agrochemical companies, as well as bioequivalence clinical and chemical services. The firm has two main divisions: Global Laboratory Services and Global Drug Discovery & Development Services. The Global Laboratory Services division offers laboratory testing support for clients involved in drug development. The Global Drug Discovery & Development Services division includes Drug Development Unit, the Drug Discovery Unit, and the Pharmaceutical Product Development Unit. Its Global Laboratory Services encompass regulated and non-regulated bioanalysis (both small and large molecules), biomarkers, genomics, manufacturing and controls analytical testing, and central laboratory services. The Drug Development Unit includes drug metabolism and pharmacokinetics, Safety and Toxicology. The firm's segments include North America and Europe and PRC.
Follow-Up Questions
FGHQF の株価パフォーマンスは？
FGHQF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Frontage Holdings Corp の主な事業テーマや業界は？
Frontage Holdings Corp は Life Sciences Tools & Services 業界、セクターは Health Care に属しています。
